Financials Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 21:00:00 17/05/2024 BST 5-day change 1st Jan Change
2.5 USD -0.79% Intraday chart for Autonomix Medical, Inc. -13.49% 0.00%

Income Statement Evolution (Annual data)

Fiscal Period: March 2022 2023
Net sales - -
EBITDA - -
EBIT 1 -13.59 -1.99
Operating Margin - -
Earnings before Tax (EBT) 1 -13.33 -1.99
Net income 1 -13.33 -1.99
Net margin - -
EPS 2 -6.197 -0.1656
Free Cash Flow - -1.108
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 07/07/23 07/07/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2022 2023
Net Debt 1 - -
Net Cash position 1 2.04 0.86
Leverage (Debt/EBITDA) - -
Free Cash Flow - -1.11
ROE (net income / shareholders' equity) - -153%
ROA (Net income/ Total Assets) - -85.3%
Assets 1 - 2.334
Book Value Per Share 2 0.9500 0.0500
Cash Flow per Share 2 0.9900 0.0700
Capex - -
Capex / Sales - -
Announcement Date 07/07/23 07/07/23
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. AMIX Stock
  4. Financials Autonomix Medical, Inc.